An overwhelming 88 per cent of Fortis shareholders voted in favour of a resolution to remove Brian Tempest, the last of the four old directors, from the board of the hospital chain and unanimously confirmed the appointment of three new independent directors at an extraordinary general meeting (EGM) on Tuesday.
The shareholders vote went against the promoter entities which voted in favour of Tempest.
Tempest, former chief executive officer (CEO) of Ranbaxy Laboratories, was appointed by Fortis founders Malvinder Singh and Shivinder Singh, who had to step down from the board in March amid allegations of siphoning off funds and after that